PIK3CA and ARID1A mutations in recurrent/metastatic cervical cancer: The NRG Oncology/Gynecologic Oncology Group-0240 National Institutes of Health Beau Biden Cancer Moonshot (LBA 2)
Year: 2023
Type: article
Source: Gynecologic Oncology
Authors: Anjali Hari, Michael Sill, Bradley Monk, Michael Birrer, Richard Penson, Heather Lankes, Virginia Filiaci, Corbin Jones, Catherine Reeves, Christopher Szot, Nilsa Ramirez, Helen Huang, Lois Ramondetta, Lisa Landrum, Ana Oaknin, Thomas Reid, Mario Leitao, Helen Michael, Lei Wei, Krishnansu Tewari
Institutions: NRG Oncology, Gynecologic Oncology Group, University of Arkansas at Little Rock, Harvard University, University of North Carolina at Chapel Hill, New York Genome Center, Leidos Biomedical Research Inc. (United States), Nationwide Children's Hospital, The University of Texas MD Anderson Cancer Center, Indiana University Indianapolis, Vall d'Hebron Institute of Oncology, University of Cincinnati, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, University of California, Irvine
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4386948463